0

544759

GLPL

img img img img
No Data Available

Goldline Pharmaceutical Ltd Share Price Update

As of the latest trading session, GOLDLINE PHARMACEUTICAL LIMITE is trading at ₹53.94, down by ₹-2.83 or -4.98% from its previous close. The stock has moved between ₹53.94 and ₹53.94 today. Over the past year, the stock has delivered a return of 0.00%. In the last month, it has returned 0.00%.

Goldline Pharmaceutical Ltd fundamentals


  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield [-]%
  • Net profit/quarter (Cr) [-]
info icon alternate text
  • Market cap (Cr) 51.80
  • P/E Ratio (TTM) 0.00
  • Beta 0.00
  • Book Value / share 20.99
  • Return on equity 38.74%
  • EPS (TTM) 0.00
  • Dividend yield [-]%
  • Net profit/quarter (Cr) 0.00
info icon alternate text

Goldline Pharmaceutical Ltd Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2025 (Values in Cr)
Revenue 28.06
Operating Expense 24.18
Net Profit 2.83
Net Profit Margin (%) 10.08
Earnings Per Share (EPS) 4.11
EBITDA 5.83
Effective Tax Rate (%) 26.42
Particulars MAR 2024 (Values in Cr)
Revenue 23.57
Operating Expense 21.04
Net Profit 1.81
Net Profit Margin (%) 7.67
Earnings Per Share (EPS) 3.01
EBITDA 4.30
Effective Tax Rate (%) 28.45
Particulars MAR 2025 (Values in Cr)
Book Value / Share 12.39
ROE % 38.74
ROCE % 27.58
Total Debt to Total Equity 1.22
EBITDA Margin 21.60
Particulars MAR 2024 (Values in Cr)
Book Value / Share 26.34
ROE % 35.70
ROCE % 22.26
Total Debt to Total Equity 1.60
EBITDA Margin 18.24
Particulars MAR 2023 (Values in Cr)
Book Value / Share 20.42
ROE % 9.56
ROCE % 12.82
Total Debt to Total Equity 1.84
EBITDA Margin 12.14
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 1.23
Total Assets 26.28
Total Liabilities 26.28
Total Equity 10.35
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 10.78
Return on Capital (%) 13.25
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.78
Total Assets 22.93
Total Liabilities 22.93
Total Equity 7.86
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 7.87
Return on Capital (%) 9.51
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.05
Total Assets 19.38
Total Liabilities 19.38
Total Equity 5.89
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 1.32
Return on Capital (%) 1.53
Particulars MAR 2025 (Values in Cr)
Net Income 3.85
Cash from Operations 3.23
Cash from Investing 0.16
Cash from Financing -2.03
Net change in Cash 0.44
Free Cash Flow 3.44
Particulars MAR 2024 (Values in Cr)
Net Income 2.52
Cash from Operations 3.11
Cash from Investing -1.10
Cash from Financing -1.07
Net change in Cash 0.73
Free Cash Flow 4.22
Particulars MAR 2023 (Values in Cr)
Net Income 0.40
Cash from Operations 2.42
Cash from Investing -1.03
Cash from Financing -1.44
Net change in Cash -0.08
Free Cash Flow 3.53
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 31.32 13.56 1.62 240.02 23.12 40.44
BLISS GVS PHARMA LTD. 283.10 22.90 2.51 2994.89 117.20 296.85
CIPLA LTD 1409.80 27.92 3.30 113883.72 1165.55 1672.20
FERMENTA BIOTECH LTD. 293.95 9.78 2.21 865.12 256.40 399.00
GLAXOSMITHKLINE PHARMACEUTICAL 2388.90 39.64 17.84 40469.41 2218.00 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 31.32 30.12 4.36 240.02 23.12 40.44
AMRUTAJAN HEALTH LTD 558.20 25.02 4.35 1613.79 490.00 789.95
ASTRAZENECA PHARMA INDIA LTD. 8687.60 104.41 27.18 21719.00 7630.00 10653.05
BLISS GVS PHARMA LTD. 283.10 30.44 2.59 2994.89 117.20 296.85

Goldline Pharmaceutical Ltd shareholding pattern

Holding
29.73%
57.29%
5.15%
7.81%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

Goldline Pharmaceutical Ltd Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
53.94 -4.98 redarrow
red-green-graph indicator
8 Bearish
8 Bullish
  • 5 Days 56.80
  • 26 Days 56.80
  • 10 Days 56.80
  • 50 Days 56.80
  • 12 Days 56.80
  • 100 Days 56.80
  • 20 Days 56.80
  • 200 Days 56.80
57.85 PIVOT
First Support 55.69 First Resistance 58.92 Second Support 54.62 Second Resistance 61.08 Third Support 52.46 Third Resistance 62.15
RSI 0.00 ADX 0.00 MACD 0.00 Williams % R -100.00 Commodity Channel Index (CCI) 0.00
Date 2026-05-19 Week 1017000.00 Same Day 1017000.00 Month 1017000.00
1 Year 0.0 3 Year 0.0
Over 1 Month
0.00% down
Over 1 Year
0.00% down
Over 3 Months
0.00% down
Over 3 Years
0.00% down
Over 6 Months
0.00% down
Over 5 Years
0.00% down

Goldline Pharmaceutical Ltd Corporate Actions

Top Gainers

Top Losers

Goldline Pharmaceutical Ltd Share Price

Goldline Pharmaceutical Limited was originally incorporated on August 2, 2004, as a private limited Company in the name of Goldline Pharmaceutical Private Limited' with the Registrar of Companies, Mumbai. Subsequently, Company was converted into a public limited Company and the name of Company was changed to Goldline Pharmaceutical Limited' w.e.f. September 23, 2013.

Company is engaged in the business of marketing pharmaceutical products under the Goldline brand. Their products are divided into five categories: Goldline Pharma, Goldline Cardinal, Goldline Aayushman, Goldline InLife, and Goldline Valiente. The pharmaceutical products marketed under the 'Goldline' brand are not manufactured by Company. Instead, they enter into contractual arrangements with third-party manufacturers, who produce the products based on market research, demand analysis, and specifications. Presently, Company maintain contractual arrangements with 15 manufacturers and 7 distributors, ensuring a stable supply chain and consistent market presence.

Company extend comprehensive material supply and procurement support to hospitals and healthcare partners. Through the promoter group entities as Numerius Healthcare Pvt Ltd & Activista Healthcare Pvt Ltd, Company manage trading and supply chain operations, thereby ensuring reliable procurement, seamless distribution, and logistical efficiency.

Company is planning the Initial Public Offer of 30,00,000 Equity Shares having the face value of Rs 10 each through Fresh Issue.

Parent organization Indian Private
NSE symbol [-]
Founded 2004
stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Goldline Pharmaceutical Ltd?

Answer Field

Goldline Pharmaceutical Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 53.94 as on May 20 2026 11:45 AM.

What is the Market Cap of Goldline Pharmaceutical Ltd Share?

Answer Field

The market cap of Goldline Pharmaceutical Ltd for NSE ₹ 0.00 & for BSE ₹ 51.80 as on May 20 2026 11:45 AM.

What is the 52 Week High and Low of Goldline Pharmaceutical Ltd?

Answer Field

The 52 Week High and Low of Goldline Pharmaceutical Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 60.00 and ₹ 53.94.

What is 1 year return for Goldline Pharmaceutical Ltd?

Answer Field

The 1 year returns on the stock has been 0.00%.

What is the P/E Ratio of Goldline Pharmaceutical Ltd Share?

Answer Field

As on May 20 2026 11:45 AM the price-to-earnings (PE) ratio for Goldline Pharmaceutical Ltd share is 0.00.

What is the PB ratio of Goldline Pharmaceutical Ltd Share?

Answer Field

As on May 20 2026 11:45 AM, the price-to-book (PB) ratio for Goldline Pharmaceutical Ltd share is 20.99.

How to Buy Goldline Pharmaceutical Ltd Share?

Answer Field

You can trade in Goldline Pharmaceutical Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Goldline Pharmaceutical Ltd Share on Bajaj Broking App?

Answer Field

To buy Goldline Pharmaceutical Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Goldline Pharmaceutical Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|